• Michalopoulou and Associates (Lawgroup) advised a foreign online medical service provider on its acquisition by a foreign company, resulting in a successful transaction.
  • Michalopoulou and Associates (Lawgroup) assisted a pharmaceutical company in submitting an application to the EOF in order to reduce the price of a generic drug.
  • Michalopoulou and Associates (Lawgroup) drafted and negotiated an advisory agreement on behalf of a US company aiming to develop an AI-based multi-omics approach to precision nutrition for the European market.
  • Michalopoulou and Associates (Lawgroup) provided a full GDPR compliance program for an oncology clinic as well as patient information on consent to treatment issues.
  • Michalopoulou and Associates (Lawgroup) advised a multinational clinical trials company on the drafting of the patient informed consent form in the context of a multicentered clinical trial.
  • Michalopoulou and Associates (Lawgroup) successfully represented before the State Council a pharma company distributing orphan drugs on the issue of her imposition of clawback on her products by EOPYY and Ministry of Health.